Home
Myriad Genetics MYGN paid Guide Consulting Services $30K for lobbying in Q2 2023 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $30,000
- Quarter
- Q2 2023
- Stock
- Myriad Genetics MYGN
- Client
- Myriad Genetics
- Reported
- 23/07/18
Up 0.0% from last quarter
What else happened in Myriad Genetics around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Myriad Genetics's other lobbying reports
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$40K
$40K
Reported 07/20
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
Under $5,000
Under $5,000
Reported 07/20
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$40K
$40K
Reported 07/18
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$30K
$30K
Reported 07/17
for Q2
- Myriad Genetics
LobbyingMyriad Genetics
LobbyingMyriad Genetics
MYGN
$10K
$10K
Reported 07/03
for Q2